Navigation Links
QB3 signs agreement to accelerate innovation
Date:10/26/2011

The California Institute for Quantitative Biosciences (QB3) has signed an agreement with the Johnson & Johnson Corporate Office of Science and Technology (COSAT) to fund University of California proof-of-concept research that brings innovative science to market.

This agreement, along with the Rogers Family Foundation of Oakland, helps fund QB3's "Bridging-the-Gap" program, initiated in 2008 to support scientific projects that have high commercial potential led by faculty at UCSF, UC Berkeley and UC Santa Cruz. These awards are intended to address the critical gap between federal funding for basic research and investments in product development. Each award typically provides $250,000 over two years for research.

Former award-winning projects include a prototype of an artificial kidney developed by Shuvo Roy, UCSF professor of bioengineering and therapeutic sciences, and an automated technique to improve prostate cancer screening, invented by Amy Herr, UC Berkeley associate professor of bioengineering.

The agreement establishes the JJSI-QB3 Awards as a component of the "Bridging-the-Gap" program and calls for annual awards over the next three years. QB3 will provide the awarded projects with services from the QB3 Startup-In-A-Box program, and potentially find space in the QB3 incubator.

"This agreement is an innovative academic-industry partnership model specifically focused on startup formation," said Neena Kadaba, QB3's director of industry alliances. "These awards are designed to provide a crucial amount of pre-commercial support to help would-be entrepreneurs address potential scientific risks in their technology before launching a company."

The nine projects funded by QB3's "Bridging-the-Gap" program to date already have resulted in five new companies and three licenses to existing firms. The five companies formed in the past two years have raised over $9 million in private and public commercial funding.
'/>"/>

Contact: Kristen Bole
kristen.bole@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert

Page: 1 2

Related biology news :

1. Hold the phone for vital signs
2. Wiley-Blackwell signs three new international open access agreements
3. Wireless network in hospital monitors vital signs
4. Reclamation signs research agreement to improve quagga and zebra mussel larvae detection
5. MU signs $5 million agreement with Coulter Translational Research Partnership Program
6. Epitomics Signs Agreement With Bayer for Antibody Technology
7. Young graphite in old rocks challenges the earliest signs of life
8. 5-minute screen identifies subtle signs of autism in 1-year olds
9. New test shows promise for detecting warning signs of joint replacement failure
10. Study provides new tool to monitor coral reef vital signs
11. Eurofins MWG Operon signs contract to supply DNA sequencing services to Research Councils
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... Md. , April 2, 2015 At ... Salt Lake City , the American College ... of five new directors to its Board.  Members of ... the ACMG and for forming and advancing its policies ... medical genetics profession. "It,s an eventful time ...
(Date:4/2/2015)... April 2, 2015 Fingerprint Cards ... sensor FPC1025 from the distributor World Peace Industrial Group ... Q2 2015 although the major part of the shipments ... be used by smartphone manufacturers in China ... included in the communicated revenue guidance of + 1 000 ...
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, ... million users across iOS and Android ... begun integrating biofeedback into the platform to allow patients ... outcomes. For the first time, patients will be able ... a dose impacts important biometrics, such as glucose levels ...
Breaking Biology News(10 mins):American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... cancer cells facing potentially lethal antiestrogen therapy recycle to ... cancer cells have receptors for the hormone estrogen, which ... Patients typically get an antiestrogen such as tamoxifen for ... says Dr. Patricia V. Schoenlein, cancer researcher in the ...
... Madison, WI 1 OCTOBER 2008 Not only ... Houston,s George R. Brown Convention Center, beginning this weekend, ... seven scientific societies, but they are bringing focus to ... Meeting under the theme of "Celebrating the International Year ...
... (NorthShore) and Northwestern University have discovered that fiber optic ... blood levels in the colonic lining (mucosa) in humans, ... cancer. The study appears in the October ... of the American Gastroenterological Association (AGA) Institute. ...
Cached Biology News:Breast cancer cells recycle to escape death by hormonal therapy 2Breast cancer cells recycle to escape death by hormonal therapy 3Earth scientists keep an eye on Texas 2Earth scientists keep an eye on Texas 3Earth scientists keep an eye on Texas 4Earth scientists keep an eye on Texas 5Breakthrough optical technology to assess colon cancer risk, accuracy 2Breakthrough optical technology to assess colon cancer risk, accuracy 3
(Date:5/4/2015)... , May 4, 2015   Tocagen Inc. ... interim data from Tocagen,s ongoing investigational studies were ... of the American Association of Neurological Surgeons (AANS)/Congress ... May 1-2, 2015, in Washington, D.C. ... held a meeting with FDA and continues to ...
(Date:5/4/2015)... May 04, 2015 Marianjoy ... patients with arm and hand impairments by acquiring ... its Oakbrook Terrace network site. , Secured through ... is a highly-regarded treatment option for patients with ... Armeo®Spring, Marianjoy becomes one of just four Illinois ...
(Date:5/1/2015)... May 1, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... announced that it has priced an underwritten registered offering ... price of $9.00 per share, and granted the underwriters ... to an additional 585,000 shares of its common stock. ... million.  The offering is expected to close on May 6, ...
(Date:5/1/2015)... A new report by  visiongain  forecasts the ... in 2019. That revenue forecast and others appear in  ... ,  published in March 2015. ... and qualitative analyses of the antithrombotic drugs market. Visiongain ... London, UK . It produces analyses to ...
Breaking Biology Technology:Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 2Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 3Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 4Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 5Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 4Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 5
... SCOTTSDALE, Ariz., Aug. 22 Regenesis Biomedical, ... Wound Therapy,System, announced today the addition of two ... directors are Peter G. Savas, Chairman and CEO ... principal with,Bederson and Company., (Logo: http://www.newscom.com/cgi-bin/prnh/20080422/LATU008 ...
... VANCOUVER, Aug. 22 /PRNewswire-FirstCall/ - OncoGenex,Pharmaceuticals (NASDAQ: ... as,custirsen sodium, received Fast Track designation from the ... docetaxel for progressive,metastatic prostate cancer. OGX-011 is currently ... and breast cancer, and is designed to,inhibit the ...
... TSX Exchange Symbol: RVX, CALGARY, Aug. 21 ... announce that it will host a live,teleconference on ... provide a corporate,update of the Company. Following the ... session., The webcast can be accessed at ...
Cached Biology Technology:Regenesis Biomedical Announces Additions to Board of Directors 2FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 2FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 3FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011 4Resverlogix Notice of Conference Call & Webcast 2
Perm/Wash Buffer 250 Tests...
Mouse monoclonal to OCIL ( Abpromise for all tested applications)....
... Large T antigen initiates replication ... replication in the presence of ... product can be used in ... Replication Kit cat. no. 8050. ...
NuParaffin Kit Application: Flow Cytometry Reactivity: Human...
Biology Products: